Response to radiation

K. E. Rosenzweig, Jana L. Fox, P. Giraud

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Computed tomography (CT) has traditionally been the standard radiographic modality for diagnosing and monitoring non-small cell; lung cancer (NSCLC) after treatment. Given the limitations of CT, the utility of 18F-fluoro-2- deoxy-glucose positron emission tomography (FDG-PET) has been investigated for the management of NSCLC, with promising findings. Its adjunctive role with CT in diagnosing and staging disease is well established. FDG-PET also has been found to be a valuable tool for radiation treatment planning because it improves the precision of lesion definition. More recently, its value for determining clinical response both during and after treatment has been explored. This review highlights the various applications of FDG-PET in the diagnosis and management of NSCLC as corroborated by clinical data, with considerations of future directions.

Original languageEnglish (US)
Pages (from-to)322-325
Number of pages4
JournalSeminars in Radiation Oncology
Volume14
Issue number4
DOIs
StatePublished - Oct 2004
Externally publishedYes

Fingerprint

Positron-Emission Tomography
tomography
Tomography
Radiation
Glucose
radiation
glucose
positrons
Lung Neoplasms
lungs
lesions
planning
cancer
cells
Direction compound

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Radiation

Cite this

Response to radiation. / Rosenzweig, K. E.; Fox, Jana L.; Giraud, P.

In: Seminars in Radiation Oncology, Vol. 14, No. 4, 10.2004, p. 322-325.

Research output: Contribution to journalArticle

Rosenzweig, K. E. ; Fox, Jana L. ; Giraud, P. / Response to radiation. In: Seminars in Radiation Oncology. 2004 ; Vol. 14, No. 4. pp. 322-325.
@article{f19f92bc1d804fe69038918740ee7471,
title = "Response to radiation",
abstract = "Computed tomography (CT) has traditionally been the standard radiographic modality for diagnosing and monitoring non-small cell; lung cancer (NSCLC) after treatment. Given the limitations of CT, the utility of 18F-fluoro-2- deoxy-glucose positron emission tomography (FDG-PET) has been investigated for the management of NSCLC, with promising findings. Its adjunctive role with CT in diagnosing and staging disease is well established. FDG-PET also has been found to be a valuable tool for radiation treatment planning because it improves the precision of lesion definition. More recently, its value for determining clinical response both during and after treatment has been explored. This review highlights the various applications of FDG-PET in the diagnosis and management of NSCLC as corroborated by clinical data, with considerations of future directions.",
author = "Rosenzweig, {K. E.} and Fox, {Jana L.} and P. Giraud",
year = "2004",
month = "10",
doi = "10.1016/j.semradonc.2004.06.002",
language = "English (US)",
volume = "14",
pages = "322--325",
journal = "Seminars in Radiation Oncology",
issn = "1053-4296",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Response to radiation

AU - Rosenzweig, K. E.

AU - Fox, Jana L.

AU - Giraud, P.

PY - 2004/10

Y1 - 2004/10

N2 - Computed tomography (CT) has traditionally been the standard radiographic modality for diagnosing and monitoring non-small cell; lung cancer (NSCLC) after treatment. Given the limitations of CT, the utility of 18F-fluoro-2- deoxy-glucose positron emission tomography (FDG-PET) has been investigated for the management of NSCLC, with promising findings. Its adjunctive role with CT in diagnosing and staging disease is well established. FDG-PET also has been found to be a valuable tool for radiation treatment planning because it improves the precision of lesion definition. More recently, its value for determining clinical response both during and after treatment has been explored. This review highlights the various applications of FDG-PET in the diagnosis and management of NSCLC as corroborated by clinical data, with considerations of future directions.

AB - Computed tomography (CT) has traditionally been the standard radiographic modality for diagnosing and monitoring non-small cell; lung cancer (NSCLC) after treatment. Given the limitations of CT, the utility of 18F-fluoro-2- deoxy-glucose positron emission tomography (FDG-PET) has been investigated for the management of NSCLC, with promising findings. Its adjunctive role with CT in diagnosing and staging disease is well established. FDG-PET also has been found to be a valuable tool for radiation treatment planning because it improves the precision of lesion definition. More recently, its value for determining clinical response both during and after treatment has been explored. This review highlights the various applications of FDG-PET in the diagnosis and management of NSCLC as corroborated by clinical data, with considerations of future directions.

UR - http://www.scopus.com/inward/record.url?scp=8844223434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8844223434&partnerID=8YFLogxK

U2 - 10.1016/j.semradonc.2004.06.002

DO - 10.1016/j.semradonc.2004.06.002

M3 - Article

C2 - 15558507

AN - SCOPUS:8844223434

VL - 14

SP - 322

EP - 325

JO - Seminars in Radiation Oncology

JF - Seminars in Radiation Oncology

SN - 1053-4296

IS - 4

ER -